- Home
- ATRA vs KRON Comparison
ATRA vs KRON Comparison
Compare ATRA & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- KRON
- Stock Information
- Founded
- ATRA 2012
- KRON 2017
- Country
- ATRA United States
- KRON United States
- Employees
- ATRA N/A
- KRON N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- KRON Medicinal Chemicals and Botanical Products
- Sector
- ATRA Health Care
- KRON Health Care
- Exchange
- ATRA Nasdaq
- KRON Nasdaq
- Market Cap
- ATRA 40.1M
- KRON 41.5M
- IPO Year
- ATRA 2014
- KRON 2020
- Fundamental
- Price
- ATRA $7.94
- KRON $0.87
- Analyst Decision
- ATRA Buy
- KRON Buy
- Analyst Count
- ATRA 5
- KRON 3
- Target Price
- ATRA $17.75
- KRON $1.63
- AVG Volume (30 Days)
- ATRA 61.5K
- KRON 1.4M
- Earning Date
- ATRA 08-11-2025
- KRON 08-07-2025
- Dividend Yield
- ATRA N/A
- KRON N/A
- EPS Growth
- ATRA N/A
- KRON N/A
- EPS
- ATRA N/A
- KRON N/A
- Revenue
- ATRA $199,732,000.00
- KRON $9,192,000.00
- Revenue This Year
- ATRA N/A
- KRON N/A
- Revenue Next Year
- ATRA N/A
- KRON N/A
- P/E Ratio
- ATRA N/A
- KRON N/A
- Revenue Growth
- ATRA 475.53
- KRON 21.16
- 52 Week Low
- ATRA $5.01
- KRON $0.65
- 52 Week High
- ATRA $18.71
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- ATRA 48.77
- KRON 64.27
- Support Level
- ATRA $7.74
- KRON $0.87
- Resistance Level
- ATRA $9.00
- KRON $0.90
- Average True Range (ATR)
- ATRA 0.54
- KRON 0.02
- MACD
- ATRA -0.12
- KRON 0.01
- Stochastic Oscillator
- ATRA 19.79
- KRON 87.65
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.